Hanmi Licenses Muscle-Preserving Obesity Drug Candidate to Genentech in $2.3 Billion Deal
Hanmi Pharmaceutical has entered into an exclusive global licensing agreement with Genentech, a member of the Roche Group, for its next-generation...
Search results for "obesity"
Why Your First Bite Matters: Strategic Eating Habits to Fight Belly Fat and High Cholesterol
The first food consumed on an empty stomach sets the tone for your body's metabolic response. When a meal begins with refined carbohydrates or sugary...
Mindless Munching and Late-Night Snacks: 5 Everyday Eating Habits That Secretly Drive Weight Gain
Unintentional weight gain does more than affect how your clothes fit—it can disrupt blood sugar, blood pressure, and...
JW Pharmaceutical Files for Phase 3 Trial of Biweekly Obesity Drug Bofanglutide
JW Pharmaceutical announced on Aug. 18 that it has submitted an Investigational New Drug application to South Korea’s...
Weight Unchanged but Waistband Tight? 5 Warning Signs of Rising Visceral Fat
If your overall weight remains stable but your stomach noticeably protrudes and your waistband feels tight, internal...
Forget Wegovy and Mounjaro: How Hanmi’s 'EPPE' Is Redefining Obesity Care
Hanmi Pharmaceutical has officially named its in-development obesity treatment "EPPE.
Olix Obesity Candidate Reduces Monkeys’ Visceral Fat by 29.2%, Outperforming Global Rival
Olix announced on July 30 that its obesity drug candidate, "OLX501A," significantly outperformed a global rival...
Depressive Symptoms Linked to Higher Fatty Liver Risk in Young Adults
Young adults in South Korea who experience depressive symptoms face roughly twice the risk of developing fatty liver...
Does Sugar Always Raise Cancer Risk? An Oncologist Explains What Really Matters
Many people feel an immediate wave of guilt when faced with a sweet dessert. In particular, the widespread belief that...
Lilly’s Retatrutide Cuts Weight by 22.6% in Phase 3 Trials, But Cardiovascular Protection Remains Unproven
Eli Lilly and Company’s next-generation obesity treatment, retatrutide, reduced body weight by up to 22.